93 results on '"F. Milord"'
Search Results
2. Portrait de la maladie de Lyme et exposition en milieu de travail, Montérégie, 2013-2018
- Author
-
F. Milord, M. Hastir, C. Ouellet, J. Pelletier, S. Sédillot-Daniel, J. Michaud-Tétreault, C. Gariépy, L. Lambert, and A. Hauyon
- Subjects
Epidemiology ,Public Health, Environmental and Occupational Health - Published
- 2022
- Full Text
- View/download PDF
3. Immunogénicité et faisabilité de la vaccination intradermique contre la rage au Québec
- Author
-
E Levac, E Cambron-Goulet, M Sow, F. Milord, and Y Bui
- Subjects
General Medicine - Published
- 2015
- Full Text
- View/download PDF
4. The changing landscape of travel health services in Canada
- Author
-
F. Milord, Susan Kuhn, Jennifer Geduld, Anne E. McCarthy, Mariama Sow, and Yen‐Giang Bui
- Subjects
medicine.medical_specialty ,Canada ,business.industry ,media_common.quotation_subject ,030231 tropical medicine ,Vaccination ,MEDLINE ,Pharmacy ,General Medicine ,03 medical and health sciences ,Health services ,0302 clinical medicine ,Family medicine ,Yellow Fever ,medicine ,Humans ,030212 general & internal medicine ,business ,Travel-Related Illness ,human activities ,Competence (human resources) ,Autonomy ,Travel Medicine ,media_common - Abstract
Canadians are increasingly travelling to areas that would necessitate a pre-travel consultation. Changes in professional regulations in Canada allow greater autonomy of nurses and pharmacists, resulting in shifts in provision of travel health services. We surveyed 824 Canadian travel clinics, 270 (33%) of whom responded. Private clinics were most common, and more likely to offer extended hours and drop-in appointments. In one province, pharmacies dominated. Half the services were relatively new and a similar proportion saw fewer than 10 patients weekly; 1/3 had a single provider. The increased spectrum of services may increase convenience for travellers but the large proportion seeing low numbers of clients will challenge providers to maintain competence.
- Published
- 2017
5. Travel‐Related Shigellosis in Quebec, Canada: An Analysis of Risk Factors
- Author
-
Manon Blackburn, Yen‐Giang Bui, Éric Levac, F. Milord, Stéphane Trépanier, and Suzanne Gagnon
- Subjects
Adult ,Male ,Shigellosis ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Databases, Factual ,Cross-sectional study ,Severe disease ,Primary care ,medicine.disease_cause ,Risk Factors ,Surveys and Questionnaires ,Epidemiology ,Shigella Infections ,medicine ,Humans ,Shigella ,Child ,Aged ,Dysentery, Bacillary ,Travel ,business.industry ,Age Factors ,Quebec ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,Indian subcontinent ,Cross-Sectional Studies ,Child, Preschool ,Communicable Disease Control ,Female ,business ,human activities ,Demography - Abstract
Background Travel-related shigellosis is not well documented in Canada although it is frequently acquired abroad and can cause severe disease. Objectives To describe the epidemiology of travel-related cases of shigellosis for Quebec (Canada) and to identify high-risk groups of travelers. Method and Data Sources We performed a random sampling of 335 shigellosis cases (from a total of 760 cases) reported in the provincial database of reportable diseases from January 1, 2004, to December 31, 2007. Each case was analyzed according to information available in the epidemiology questionnaire. Total number of trips by region from Statistics Canada was used as denominator to estimate the risk according to region of travel. Results Annually, between 43 and 54% of the shigellosis cases were reported in travelers, 45% of whom were aged between 20 and 44 years. Children under 11 years accounted for nearly 16% of cases, but represent only 4% of travelers. Most cases in travelers were serogroups Shigella sonnei (50%) or Shigella flexneri (45%). Almost 31% of cases were reported between January and March. The majority (64%) were acquired in Central America, Mexico, or the Caribbean. However, the Indian subcontinent, Africa, and South America had the highest ratio of number of cases per number of trips. Tourists represented 76% of the cases; 62% of them had traveled for
- Published
- 2014
- Full Text
- View/download PDF
6. Cases of Malaria, Hepatitis A, and Typhoid Fever Among VFRs, Quebec (Canada)
- Author
-
F. Milord, Stéphane Trépanier, Yen‐Giang Bui, Sylvie Provost, Manon Blackburn, and Suzanne Gagnon
- Subjects
Adult ,Male ,Veterinary medicine ,Visiting friends and relatives ,Typhoid fever ,Young Adult ,Risk groups ,Risk Factors ,parasitic diseases ,medicine ,Humans ,Registries ,Typhoid Fever ,Africa South of the Sahara ,Retrospective Studies ,Travel ,biology ,business.industry ,Incidence ,Quebec ,Hepatitis A ,Plasmodium falciparum ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Malaria ,Indian subcontinent ,Design study ,Female ,business ,Follow-Up Studies ,Demography - Abstract
Background. Visiting friends and relatives (VFRs), especially young VFRs, are increasingly recognized in the industrialized world as a high-risk group of travelers. Methods. We performed a descriptive, cross-sectional design study of cases of malaria, hepatitis A, and typhoid reported to the Quebec registry of notifiable diseases between January 2004 and December 2007, occurring in VFRs and non-VFRs travelers. Results. VFRs account for 52.9% of malaria cases, 56.9% of hepatitis A cases, and 94.4% of typhoid cases reported in Quebec travelers. Almost all (91.6%) of the malaria cases among VFRs were acquired in Africa, particularly in sub-Saharan Africa. An important proportion of malaria cases among VFRs (86.4%) were due to Plasmodium falciparum. The vast majority (76.6%) of typhoid fever cases among VFRs were reported by travelers who had visited the Indian subcontinent. Among VFRs, 40% of total cases were under 20 y of age, compared to less than 6% among non-VFRs. Those under 20 years of age also accounted for 16.9% of malaria cases, 50% of typhoid cases, and 65.2% of hepatitis A cases among VFRs. Conclusion. Our study clearly shows that VFR children should be a primary target group for pre-travel preventive measures.
- Published
- 2011
- Full Text
- View/download PDF
7. Cyclospora cayetanensis: a description of clinical aspects of an outbreak in Quebec, Canada
- Author
-
M. St-Amour, D. Ramsay, E. Lampron-Goulet, E. Levac, and F. Milord
- Subjects
Adult ,Diarrhea ,Male ,Veterinary medicine ,Pediatrics ,medicine.medical_specialty ,Restaurants ,Epidemiology ,Nausea ,Population ,Attack rate ,Cyclospora cayetanensis ,Disease Outbreaks ,Young Adult ,Food Parasitology ,medicine ,Humans ,Cyclospora infection ,Cyclosporiasis ,education ,Aged ,education.field_of_study ,biology ,Quebec ,Outbreak ,Middle Aged ,biology.organism_classification ,medicine.disease ,Cyclospora ,Infectious Diseases ,Ocimum basilicum ,Female ,medicine.symptom ,Headaches - Abstract
SUMMARYCyclospora cayetanensis is an emerging infectious agent. The aim of this study was to describe an outbreak that occurred in 250 adults exposed to contaminated food, focusing on the duration and relapses of symptoms, complications and evidence of local transmission. This outbreak affected workers who ate in a restaurant in June 2005. Cyclospora sp. was observed in the stools of 20 cases and 122 probable cases were identified. The attack rate was estimated at 89%. Main symptoms were diarrhoea (96%), nausea (88%), fatigue (87%), abdominal cramps (85%), fever (52%) and headaches (45%). Contaminated fresh basil originating from a Mexican farm, used to prepare an uncooked appetizer, was identified as the source. In this non-endemic population of immunocompetent adults, Cyclospora infection presents with watery diarrhoea lasting from 4 to 18 days and fatigue lasting from 11 to 42 days. For a small proportion of affected persons, recovery can be delayed.
- Published
- 2011
- Full Text
- View/download PDF
8. Clinical presentation of reported lyme disease cases among children from Quebec (Canada) between 2009-2017
- Author
-
J. Jiang, L. Lambert, G. Jolicoeur, M.-A. Hacala, M. Leclerc, E. Phan, and F. Milord
- Subjects
Microbiology (medical) ,Pediatrics ,medicine.medical_specialty ,Infectious Diseases ,Lyme disease ,business.industry ,medicine ,General Medicine ,Presentation (obstetrics) ,medicine.disease ,business - Published
- 2019
- Full Text
- View/download PDF
9. Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec
- Author
-
E Cambron-Goulet, F. Milord, M Sow, E Levac, and Y Bui
- Subjects
Pediatrics ,medicine.medical_specialty ,Booster (rocketry) ,business.industry ,Immunogenicity ,Research ,General Medicine ,Booster dose ,medicine.disease ,Vaccination ,Rabies vaccine ,Immunization ,medicine ,Rabies ,business ,medicine.drug ,Blood sampling - Abstract
Objectives Preexposure vaccination against rabies is recommended for some travellers and individuals exposed to the virus through their work. At a cost of at least $150 per intramuscular (IM) dose, few follow this recommendation. In Canada, provided certain conditions are met, the National Advisory Committee on Immunization (NACI) and the Comite d'immunisation du Quebec allow a more economical alternative, intradermal vaccine administration (ID) which uses 1/10 the IM dose. The purpose of this study is to assess the feasibility and immunogenicity of intradermal preexposure vaccination. Methods Students and employees at the Faculty of Veterinary Medicine received three doses of ImovaxRage™ (Sanofi Pasteur) inactivated, human diploid cell rabies vaccine at days 0, 7 and 21 or 28. An IM or ID booster dose was administered after two years when indicated. Outcomes Among the 159 participants who received three doses, 139 underwent serological testing in the year following vaccination and all achieved protective antibody levels. The antibody level was higher when measured within five weeks of the third dose. When the serological control was performed two years later, 65% of participants had a
- Published
- 2015
10. The Impact of Syphilis, HIV-1, and HIV-2 on Pregnancy Outcome in Bissau, Guinea-Bissau
- Author
-
Inacio C. Alvarenga, Patrick Morency, Annie-Claude Labbé, Alexandre P. Mendonca, Francisco Dias, F. Milord, Alfredo Claudino Alves, Shabbar Jaffar, Eric Frost, and Jacques Pépin
- Subjects
Adult ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Population ,HIV Infections ,Dermatology ,Abortion ,Rapid plasma reagin ,Acquired immunodeficiency syndrome (AIDS) ,Pregnancy ,Risk Factors ,Prenatal Diagnosis ,medicine ,Humans ,Guinea-Bissau ,Syphilis ,Pregnancy Complications, Infectious ,education ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Obstetrics ,Pregnancy Outcome ,Public Health, Environmental and Occupational Health ,medicine.disease ,Surgery ,Infectious Diseases ,Case-Control Studies ,HIV-2 ,HIV-1 ,Female ,business ,Treponematosis - Abstract
Background: Syphilis remains a major cause of fetal loss and neonatal mortality in sub-Saharan Africa. Guinea-Bissau is the epicenter of the HIV-2 epidemic, and little is known about the impact of HIV-2 on pregnancy. Goal: To understand better the impact of maternal syphilis and HIV-2 on the outcomes of pregnancy in Bissau, Guinea-Bissau. Study Design: Using a case-control design, maternal syphilis and HIV-2 seropositive results were examined in relation to adverse outcomes of pregnancy. From June 1997 to April 1998, women presenting to the Simao Mendes hospital of Bissau for a delivery or a spontaneous abortion were invited to participate in the study, and 1341 women were enrolled. The 743 control subjects were women who had delivered a term neonate with a birthweight greater than 2500 g that survived the first 28 days of life. The cases were classified into five groups of mothers according to the outcome of pregnancy: stillbirths (n = 185), spontaneous abortions (n = 89), premature deliveries (n = 256), small-for-gestation-age babies (n = 55), and neonatal deaths (n = 13). Results: Among the control subjects, the prevalences of serologic syphilis and HIV infection were 3.9% and 7.9%, respectively. Positive syphilis serology results together with a rapid plasma reagin titer of 1:16 or more were associated with delivery of a stillborn (adjusted odds ratio [AOR], 6.05) and premature delivery (AOR, 2.98). In Bissau, the population-attributable risk fraction of syphilis was 7.2% (95% CI, 2.2-11.9%) for stillbirths and only 2.4% (95% CI, 0-5.8%) for premature deliveries. Spontaneous abortions, delivery of a small-for-gestation-age baby, and neonatal deaths were not associated with positive syphilis serology results. None of these pregnancy outcomes was significantly associated with HIV-2 infection. Conclusions: The effect of syphilis on the outcome of pregnancy in West Africa is similar to that reported from other parts of Africa. However, because the prevalence of positive syphilis serology results is relatively low, the impact of screening for syphilis on the outcome of pregnancy is likely to be relatively modest. The findings from this study confirm the absence of association between HIV-2 and an adverse pregnancy outcome.
- Published
- 2002
- Full Text
- View/download PDF
11. Epidemiological evidence for immunity following Trypanosoma brucei gambiense sleeping sickness
- Author
-
Theophile Niyonsenga, Nzambi Khonde, F. Milord, Philippe De Wals, and Jacques Pépin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Trypanosoma brucei gambiense ,Cohort Studies ,Immunity ,Internal medicine ,Epidemiology ,medicine ,Animals ,Humans ,African trypanosomiasis ,Child ,Aged ,Retrospective Studies ,First episode ,biology ,Incidence ,Incidence (epidemiology) ,Infant, Newborn ,Public Health, Environmental and Occupational Health ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,biology.organism_classification ,Trypanosomiasis, African ,Infectious Diseases ,Child, Preschool ,Immunology ,Democratic Republic of the Congo ,Trypanosoma ,Female ,Parasitology ,Immunologic Memory ,Trypanosomiasis ,Cohort study - Abstract
In order to investigate whether protective immunity appears after Trypanosoma brucei gambiense sleeping sickness, we undertook a retrospective cohort study of 3 remote villages in central Zaire (total population 1431), in which 38% of all adults had a past history of human African trypanosomiasis. Among adults previously diagnosed with trypanosomiasis and treated, the risk of a second episode of trypanosomiasis during the 10 years period of observation was only 15% (with a 24 months refractory period) and 30% (without a refractory period) of the risk of a first episode in adults never previously diagnosed. We could not demonstrate a similar difference among children, to some extent because only a few of them were diagnosed for a first time with trypanosomiasis. Our findings suggest that very significant immunity appears after Gambian sleeping sickness, and that developing a vaccine against this subspecies of trypanosomes is biologically plausible.
- Published
- 1995
- Full Text
- View/download PDF
12. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness
- Author
-
F. Milord, Theophile Niyonsenga, A.N. Khonde, P. De Wals, Bokelo Mpia, L. Loko, and Jacques Pépin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Prednisolone ,Encephalopathy ,Melarsoprol ,Biology ,Gastroenterology ,Cohort Studies ,Risk Factors ,Internal medicine ,White blood cell ,medicine ,Humans ,African trypanosomiasis ,Child ,Aged ,Retrospective Studies ,Brain Diseases ,Incidence ,Mortality rate ,Infant, Newborn ,Public Health, Environmental and Occupational Health ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,Regimen ,Trypanosomiasis, African ,Infectious Diseases ,medicine.anatomical_structure ,Child, Preschool ,Multivariate Analysis ,Immunology ,Democratic Republic of the Congo ,Dimercaprol ,Female ,Parasitology ,Trypanosomiasis ,medicine.drug - Abstract
This paper reviews the incidence of, and risk factors for, drug-induced encephalopathy and mortality (from all causes) during treatment with melarsoprol of 1083 patients with Trypanosoma brucei gambiense sleeping sickness in Nioki hospital (Zaire) between 1983 and 1990. Sixty-four patients (5.9%) developed encephalopathy and 62 (5.7%) died: 43 from reactive encephalopathy and 19 from other causes. Univariate and multivariate analyses showed that the administration of prednisolone reduced significantly the incidence of encephalopathy and mortality during treatment, especially in patients with trypanosomes observed in the cerebrospinal fluid (CSF) and/or with a CSF white blood cell (WBC) count of 100 or more per mm3. The risk of encephalopathy was associated more strongly with the CSF WBC count than with the presence of CSF trypanosomes. In the subgroup of patients with a CSF WBC count of 100 or more mm3, changing the melarsoprol regimen to 3 series of 3 injections instead of 3 series of 4 injections halved the mortality rate during treatment. Treatment of patients who do develop reactive encephalopathy with the heavy metal chelator dimercaprol, in addition to intravenous steroids and anticonvulsants, may be harmful. The data suggest that a further reduction of the total dose of melarsoprol may decrease toxicity without jeopardizing efficacy.
- Published
- 1995
- Full Text
- View/download PDF
13. Investigations of foodborne outbreaks caused by a parasite in Canada
- Author
-
B. Dixon, L. Landry, and F. Milord
- Subjects
Veterinary medicine ,medicine.medical_specialty ,biology ,business.industry ,Foodborne outbreak ,Outbreak ,biology.organism_classification ,Food safety ,Cyclospora cayetanensis ,Cyclospora ,Environmental health ,parasitic diseases ,Epidemiology ,medicine ,Parasite hosting ,business ,Food contaminant - Abstract
Two well-documented foodborne outbreaks of diarrheal illness associated with infection with Cyclospora cayetanensis occurred in Canada in the spring and early summer of 2005. One outbreak occurred in Ontario and the other in Quebec. This chapter describes these outbreaks and the epidemiological and traceback investigations that followed, as well as the risk management decisions that were made. A number of surveillance studies have reported the presence of this parasite in a variety of vegetables, including leafy greens in Nepal, Egypt, and Costa Rica, market vegetables in Peru, water spinach in Cambodia, and herbs in Vietnam. However, there are a variety of hurdles faced in making an association between a specific food and illnesses resulting from infection with protozoan parasites.
- Published
- 2012
- Full Text
- View/download PDF
14. Contributor contact details
- Author
-
J. Hoorfar, D. Schoder, M. Wagner, F. Allerberger, A.G. Stewart, R. Vivancos, A. Keenan, C. Theodore, S. Ghebrehewet, M.A. Smith, L.D. Goodridge, J.T. LeJeune, L. Beutin, Marja-Liisa Hänninen, Ari Hörman, Dr Monika Ehling-Schulz, U. Messelhäusser, M.F. Dutton, Brent Dixon, L. Landry, F. Milord, Kieran N. Jordan, Karen Hunt, Edward M. Fox, V. Biguzzi, G. Pezzotti, M.V. Gianfranceschi, D. De Medici, Erik Nordkvist, N.C. Elviss, F. Jørgensen, Suresh D. Pillai, Knut Rudi, Petr Ricanek, Tone Tannæs, Stephan Brackmann, Gøri Perminow, Morten H. Vatn, A. Wingstrand, T. Jensen, G. Sørensen, S. Gubbels, L.J. Porsbo, S. Ethelberg, G.O. Bjerager, M.K. Kjeldsen, M. Torpdahl, K.G. Kuhn, R. Knutsson, V. Båverud, M. Elvander, E. Olsson Engvall, K. Eliasson, S. Sternberg Lewerin, D. Orlando, null Dennis, F.M.C. Sigit Setyabudi, M. Suci Hardianti, Anca Ioana Nicolau, L.S. Christensen, Per Häggblom, K.N. Jordan, K. Hunt, E.H. Drosinos, P.N. Skandamis, S.G. Charalambidou, D.W. Eddy, I.N. Haynes, Peter Feng, Jeffrey L. Kornacki, C. Löfström, M.H. Josefsen, F. Hansen, J. Sumner, I. Jenson, T. Ross, M.J. Walker, J. Zentek, F. Knorr, A. Mader, H. Schafft, Claudio F. Cardoso, Adriano G. Cruz, José A.F. Faria, Uelinton M. Pinto, N.Z. Ballin, E.E. Nielsen, J. Hemmer-Hansen, D. Bekkevold, A. Holst-Jensen, A.R. Ali, L. Emanuelsen, T.M. Grønbeck, S.B. Harbo, C. Skjæret, B. Spilsberg, H.-U. Waiblinger, J. Sørensen, and S. Bisgaard
- Published
- 2012
- Full Text
- View/download PDF
15. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy
- Author
-
Theophile Niyonsenga, Jacques Pépin, Bokelo Mpia, L. Loko, F. Milord, and A.N. Khonde
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,Prednisolone ,Trypanosoma brucei gambiense ,medicine.medical_treatment ,Encephalopathy ,Melarsoprol ,Sex Factors ,Recurrence ,Risk Factors ,Internal medicine ,parasitic diseases ,medicine ,Animals ,Humans ,African trypanosomiasis ,Treatment Failure ,Risk factor ,Child ,Aged ,Chemotherapy ,business.industry ,Public Health, Environmental and Occupational Health ,Infant ,General Medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Surgery ,Trypanosomiasis, African ,Infectious Diseases ,Child, Preschool ,Multivariate Analysis ,Democratic Republic of the Congo ,Encephalitis ,Female ,Parasitology ,business ,Trypanosomiasis ,medicine.drug - Abstract
1083 patients with late-stage Trypanosoma brucei gambiense sleeping sickness were treated with melarsoprol in Nioki hospital, Zaire, between 1983 and 1990. Sixty-two (5.7%) died during treatment. Of the 1021 patients who survived the treatment, 63 (6.2%) subsequently relapsed, 58 (92%) of whom were diagnosed within 2 years of melarsoprol treatment. There was no evidence of an increase in the frequency of treatment failures during the study period, and the rate of relapses that we documented is comparable to that reported from Zaire more than 30 years ago. Relapses were more frequent among patients who had trypanosomes seen in the cerebrospinal fluid (CSF) at the time of the initial diagnosis (odds ratio [OR] = 2.76, 95% confidence interval [CI] = 1.65-4.63, P = 0.0001). Male patients had twice as many relapses as females (OR = 2.00, 95% CI = 1.19-3.36, P = 0.009), which was partly explained by males having trypanosomes in the CSF more often than females. There were important geographical variations in the frequency of relapses within the territory of the Nioki rural health zone, suggesting that the circulation of trypanosomes was geographically limited. Prednisolone treatment did not increase the risk of treatment failure, nor did decreasing the total dose of melarsoprol from 12 to 9 injections for patients with > or = 100 white blood cells/mm3 of CSF. Since patients with trypanosomes in the CSF are also those who are at the highest risk of melarsoprol-induced encephalopathy, more aggressive treatment regimens cannot be recommended.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1994
- Full Text
- View/download PDF
16. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness
- Author
-
L. Ethier, Lutete Loko, Bokelo Mpia, F. Milord, and Jacques Pépin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Eflornithine ,Adolescent ,Anemia ,Trypanosoma brucei gambiense ,Melarsoprol ,Biology ,Gastroenterology ,Drug Administration Schedule ,Cerebrospinal fluid ,Pharmacokinetics ,Seizures ,Internal medicine ,medicine ,Animals ,Humans ,African trypanosomiasis ,Child ,Body surface area ,Age Factors ,Public Health, Environmental and Occupational Health ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,Trypanosomiasis, African ,Infectious Diseases ,Child, Preschool ,Injections, Intravenous ,Immunology ,Female ,Parasitology ,Trypanosomiasis ,medicine.drug - Abstract
Eflornithine (difluoromethylornithine, DFMO) has recently been approved for the treatment of Trypanosoma brucei gambiense trypanosomiasis. Treatment failures have been infrequent but have occurred among patients treated with oral DFMO only, and among children. To investigate the higher frequency of failures observed in young patients, DFMO trough concentrations in serum and cerebrospinal fluid (CSF) were measured at the end of treatment in 13 children and 50 adults who had received 200 mg/kg intravenously every 12 h for 14 d. Mean DFMO concentration in CSF was significantly lower among children aged less than 12 years when compared to older patients (25.1 vs 68.9 nmol/mL, P < 0.001). Mean serum concentration was also lower in children (49.2 vs 87.5 nmol/mL, P = 0.03). Among patients who received DFMO as initial therapy for sleeping sickness, the mean CSF/serum ratio was lower in children (0.41 vs 0.91, P < 0.005). The 3 patients who failed DFMO treatment had CSF trough concentrations around or below 50 nmol/mL. Convulsions and anaemia were associated with higher drug levels and previous therapy with melarsoprol. The lower CSF drug concentrations observed in children could result from higher renal clearance and different CSF pharmacokinetics of DFMO in that age group. To avoid treatment failures, a 6-hourly regimen as well as higher DFMO dosage based on body surface area rather than on weight are recommended for children.
- Published
- 1993
- Full Text
- View/download PDF
17. The Indian Ocean paradox revisited: HIV and sexually transmitted infections in the Comoros
- Author
-
Yasmina Dada, Aloys Kamuragiye, F. Milord, Mejdi Khelifa, Jean Youssouf, Jean-Pierre Manshande, Jacques Pépin, and Eric Frost
- Subjects
Sexually transmitted disease ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Endemic Diseases ,Cross-sectional study ,Population ,Sexually Transmitted Diseases ,HIV Infections ,Dermatology ,Comoros ,Interviews as Topic ,Acquired immunodeficiency syndrome (AIDS) ,Epidemiology ,medicine ,Humans ,Pharmacology (medical) ,Sex organ ,education ,education.field_of_study ,business.industry ,Public Health, Environmental and Occupational Health ,virus diseases ,Middle Aged ,medicine.disease ,Sex Work ,Infectious Diseases ,Cross-Sectional Studies ,Sexual Partners ,Immunology ,Yaws ,Syphilis ,Female ,business ,Treponematosis ,Demography - Abstract
The combination of high sexually transmitted infection (STI) prevalence and low HIV prevalence has been described as the Indian Ocean paradox. To investigate current epidemiology of HIV and STI in the Comoros, we conducted cross-sectional surveys of a representative sample of the adult population, and convenience samples of female sex workers and male STI patients. Only one (0.025%) of 3990 community participants was HIV-infected, while 142 (3.6%) had treponemal antibodies. Treponemal antibodies were not associated with past genital ulcers, number of sexual partners or adverse outcomes of pregnancies; their prevalence did not increase with age and there was no concordance within couples. Thus, most individuals with treponemal antibodies were probably infected during childhood with a non-venereal treponematosis. Only 1/70 (1.4%) and 0/83 sex workers sampled in 2004 and 2005 were HIV-infected. The Comoros have been protected by their insular status, male circumcision and paucity of syphilis. HIV control should focus on sex workers.
- Published
- 2007
18. Evaluation of the rubella surveillance system in Quebec
- Author
-
P. De Wals, L. Perron, and F. Milord
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,business.industry ,Family medicine ,medicine ,lcsh:RC109-216 ,Original Article ,medicine.disease ,business ,Rubella ,Virology ,lcsh:Infectious and parasitic diseases - Abstract
OBJECTIVE: To evaluate the validity of information in the rubella surveillance system in Quebec.DATA AND METHODS: Cases of rubella in the provincial registry of notifiable diseases, "Maladies à declaration obligatoire" (MADO), from 1994 to 1996 were matched with laboratory-identified cases and with cases in a reference file created from all case investigation records of regional departments of public health for the same period. Sensitivity and the proportion of cases in agreement were calculated.RESULTS: Compared with laboratories, the sensitivity of the provincial registry was 56%. Compared with the reference file, global sensitivity (confirmed cases plus clinical cases) was 58% and the positive predictive value was 50%. Of the 356 cases reported to regional public health departments, 65% were classified in the same diagnostic category (confirmed case, clinical case, excluded case) by public health professionals and a group of experts (weighted kappa=0.32). Information on rubella vaccination status was missing in 25% of cases in the MADO file for rubella.CONCLUSIONS: Notification of positive results for immunoglobulin M antibodies and viral cultures should be required of all laboratories. Uniform procedures should be adopted and applied for the validation of cases that are reported to regional departments of public health. In the context of the rarefaction of rubella, any immunoglobulin M-positive result should be interpreted using all available epidemiological information.
- Published
- 2000
19. First known outbreak of colonizing vancomycin-resistant enterococci in Quebec
- Author
-
A, Fortin, F, Milord, M, Guay, M A, d'Halewyn, P, Vigeant, and G, Leblanc
- Subjects
Adult ,Aged, 80 and over ,Male ,Cross Infection ,Quebec ,Drug Resistance, Microbial ,Middle Aged ,Anti-Bacterial Agents ,Disease Outbreaks ,Vancomycin ,Humans ,Female ,Enterococcus ,Gram-Positive Bacterial Infections ,Aged - Published
- 1998
20. Hepatitis A in restaurant clientele and staff--Quebec
- Author
-
A, Fortin and F, Milord
- Subjects
Adult ,Male ,Restaurants ,Food Handling ,Incidence ,Disease Transmission, Infectious ,Quebec ,Humans ,Female ,Hepatitis A ,Middle Aged ,Disease Outbreaks - Published
- 1998
21. Resurgence of pertussis in Montérégie, Quebec--1990-1994
- Author
-
F, Milord
- Subjects
Adult ,Pertussis Vaccine ,Cross-Sectional Studies ,Adolescent ,Whooping Cough ,Child, Preschool ,Incidence ,Infant, Newborn ,Quebec ,Humans ,Infant ,Child ,Disease Outbreaks - Published
- 1995
22. The treatment of human African trypanosomiasis
- Author
-
J, Pépin and F, Milord
- Subjects
Trypanosoma brucei rhodesiense ,Eflornithine ,Trypanosomiasis, African ,Trypanosoma brucei gambiense ,Animals ,Humans ,Melarsoprol ,Nifurtimox ,Suramin ,Diminazene ,Trypanocidal Agents ,Pentamidine - Published
- 1994
23. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness
- Author
-
F Milord, J Pépin, L Ethier, L Loko, and B Mpia
- Subjects
Diarrhea ,Male ,medicine.medical_specialty ,Eflornithine ,Hospitals, Rural ,Trypanosoma brucei gambiense ,Administration, Oral ,Melarsoprol ,Gastroenterology ,Leukocyte Count ,Recurrence ,Seizures ,Internal medicine ,medicine ,Animals ,Infusions, Intravenous ,Cerebrospinal Fluid ,business.industry ,General Medicine ,medicine.disease ,Hematologic Diseases ,Trypanosomiasis, African ,Bone marrow suppression ,Toxicity ,Immunology ,Democratic Republic of the Congo ,Female ,medicine.symptom ,business ,Trypanosomiasis ,After treatment ,medicine.drug - Abstract
The usual first-line treatment for Trypanosoma brucei gambiense sleeping sickness is melarsoprol, but when that fails the outlook has hitherto been grim. The polyamine synthesis inhibitor eflornithine (difluoromethylornithine, DFMO) has emerged as an alternative therapy. 207 patients with late-stage T b gambiense sleeping sickness were treated in rural Zaire with three different regimens of DFMO in an open-trial design. During treatment, trypanosomes disappeared from the CSF of all 87 patients in whom parasites had been seen before DFMO administration, and there was a sharp fall in CSF white cell count from a mean of 186/microliters to 21/microliters. 152 patients have been followed for at least a year after DFMO treatment, and only 13 (9%) have relapsed. Treatment failures were more common in children less than 12 years, among patients treated with oral DFMO only, and among patients who received DFMO as the initial treatment of their recently diagnosed trypanosomiasis. Toxicity was acceptable. Only 4 patients died during or shortly after treatment. Bone marrow suppression resulting in anaemia (43%) or leucopenia (53%) was common but bore little consequence. This open trial shows that DFMO is as active as and possibly less toxic than melarsoprol. For economic and logistic reasons DFMO may not be the first-choice therapy in rural Africa but for the vast majority of patients who relapse after melarsoprol DFMO will be curative.
- Published
- 1992
24. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire
- Author
-
F. Meurice, F. Milord, Jacques Pépin, Bokelo Mpia, L. Loko, and L. Ethier
- Subjects
Male ,medicine.medical_specialty ,Eflornithine ,Trypanosoma brucei gambiense ,Drug Resistance ,Melarsoprol ,Gastroenterology ,Cerebrospinal fluid ,Recurrence ,Internal medicine ,White blood cell ,medicine ,Animals ,Humans ,African trypanosomiasis ,Nifurtimox ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,General Medicine ,medicine.disease ,biology.organism_classification ,Regimen ,Infectious Diseases ,medicine.anatomical_structure ,Trypanosomiasis, African ,Immunology ,Toxicity ,Trypanosoma ,Democratic Republic of the Congo ,Parasitology ,Female ,business ,medicine.drug ,Follow-Up Studies - Abstract
Thirty patients with arseno-resistant Trypanosoma brucei gambiense sleeping sickness were treated with high-dose nifurtimox (30 mg/kg/d for 30 d). During treatment, the cerebrospinal fluid (CSF) white blood cell (WBC) count decreased in all patients except one (mean CSF WBC count before nifurtimox: 117/mm3; after nifurtimox: 25/mm3), and trypanosomes disappeared from the CSF of all 9 patients in whom parasites had been demonstrated before nifurtimox. Among 25 patients seen at least once after treatment, 9 (36%) have relapsed so far. High-dose nifurtimox was significantly toxic: one patient died during treatment and 8 others developed adverse neurological effects. High-dose nifurtimox seems more effective than the previously used regimen (15 mg/kg/d for 60 d), but at the expense of significant toxicity.
- Published
- 1992
25. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis
- Author
-
F. Milord and J. Pepin
- Subjects
Lymphocyte ,Trypanosoma brucei gambiense ,Encephalopathy ,Melarsoprol ,Biology ,Leukocyte Count ,Cerebrospinal fluid ,Immune system ,Antigen ,Risk Factors ,parasitic diseases ,medicine ,Animals ,Humans ,African trypanosomiasis ,Brain Diseases ,Public Health, Environmental and Occupational Health ,General Medicine ,medicine.disease ,Infectious Diseases ,medicine.anatomical_structure ,Trypanosomiasis, African ,Immunology ,Parasitology ,Dimercaprol ,Trypanosomiasis ,medicine.drug - Abstract
Data on 598 patients with Trypanosoma brucei gambiense sleeping sickness, with abnormal cerebrospinal fluid (CSF) and treated with melarsoprol, were reviewed to determine risk factors for drug-induced encephalopathy. The incidence of melarsoprol-induced encephalopathy was increased in patients with trypanosomes present in the CSF, in patients with a high CSF lymphocyte count, and among patients in whom no trypanosomes were found in either the blood or the lymph node aspirate. Among patients with trypanosomes in the CSF, the risk of encephalopathy was similar whether or not they also had trypanosomes seen in the haemolymphatic system. Dimercaprol, a heavy metal chelator, did not reduce the case-fatality rate of patients with encephalopathy. These observations and others are compatible with the hypothesis that an immune phenomenon is involved in the pathogenesis of melarsoprol-induced encephalopathy. Whether the basic mechanism relates to deposits of immune complexes in the central nervous system or to the release of trypanosomal antigens which subsequently bind to brain cells and attract antibodies or T lymphocytes, the rapidity with which trypanosomal antigens are released may be critical, and very aggressive therapeutic schemes may result in higher toxicity, especially in patients with an impaired blood-brain barrier.
- Published
- 1991
26. TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESS
- Author
-
F. Milord, Bokelo Mpia, Diabakana Mansinsa, Claude Guern, L. Ethier, and Jacques Pépin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Prednisolone ,Trypanosoma brucei gambiense ,medicine.medical_treatment ,Encephalopathy ,Administration, Oral ,Melarsoprol ,Arsenicals ,Leukocyte Count ,Random Allocation ,Sex Factors ,Internal medicine ,parasitic diseases ,medicine ,Animals ,Humans ,In patient ,Prospective Studies ,Coma ,Child ,Aged ,Clinical Trials as Topic ,Chemotherapy ,business.industry ,Incidence (epidemiology) ,Infant, Newborn ,Infant ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Surgery ,Trypanosomiasis, African ,Child, Preschool ,Female ,business ,Trypanosomiasis ,Follow-Up Studies ,medicine.drug - Abstract
In a prospective randomised trial, 620 patients who had Trypanosoma brucei gambiense trypanosomiasis with central nervous system involvement were treated either with prednisolone plus melarsoprol or with melarsoprol only. 598 patients were evaluable: morbidity and death associated with melarsoprol-induced encephalopathy was reduced in patients who were given prednisolone. The two groups did not differ either in the incidence of other complications of melarsoprol therapy or in relapse rate after melarsoprol therapy. The cost of prednisolone would be outweighed by savings on the treatment of encephalopathies in such patients.
- Published
- 1989
- Full Text
- View/download PDF
27. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire
- Author
-
F. Milord, D. Degroof, H. Bruneel, L. Ethier, Jacques Pépin, Bokelo Mpia, and F. Meurice
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Adolescent ,Gastrointestinal Diseases ,Nitrofurans ,medicine.medical_treatment ,Trypanosoma brucei gambiense ,Gastroenterology ,Leukocyte Count ,Cerebrospinal fluid ,Oral administration ,Cerebellar Diseases ,Internal medicine ,medicine ,Animals ,Humans ,African trypanosomiasis ,Nifurtimox ,Child ,Chemotherapy ,Clinical Trials as Topic ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,Infant ,General Medicine ,medicine.disease ,biology.organism_classification ,Clinical trial ,Infectious Diseases ,Trypanosomiasis, African ,Child, Preschool ,Immunology ,Trypanosoma ,Democratic Republic of the Congo ,Parasitology ,Female ,business ,Trypanosomiasis ,medicine.drug - Abstract
Twenty-five patients with arseno-resistant Trypanosoma brucei gambiense sleeping sickness were treated with oral nifurtimox, 12-17 mg/kg/d for 60 d. During treatment, trypanosomes disappeared from the cerebrospinal fluid (CSF) of 7/7 patients; the CSF infections; leucocyte was significantly lower at the end of treatment than before it was begun (pre-nifurtimox: 124.2 (+/- 149.3) per microliter; post-nifurtimox: 11.9 (+/- 12.1) per microliter; P less than 0.001). Nifurtimox was well tolerated, with gastro-intestinal disturbances in 6 patients and a reversible cerebellar syndrome in 2 patients. Among the 19 patients seen at least once at follow-up, 12 (63%) relapsed. The other 7 patients have been followed for 3-18 months, and the CSF remained completely normal in 4 of them. This study confirms that nifurtimox has some activity against T.b. gambiense, but a daily dosage higher than 15 mg/kg/d will be necessary to achieve cure of most patients.
- Published
- 1989
28. [Characteristics of the hemophiliac population of the cantons of the east]
- Author
-
F, Milord, M, Lépine-Martin, C, Paré, and R, Losito
- Subjects
Adult ,Hospitals, University ,Adolescent ,Child, Preschool ,Quebec ,Humans ,Blood Coagulation Tests ,Child ,Hemophilia A - Published
- 1983
29. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense]
- Author
-
J, Pepin, C, Guern, F, Milord, L, Ethier, M, Bokelo, and P J, Schechter
- Subjects
Male ,Eflornithine ,Trypanosomiasis, African ,Trypanosoma brucei gambiense ,Animals ,Humans ,Infant ,Female - Abstract
The authors describe their experience with two cases of congenital Trypanosoma brucei-gambiense trypanosomiasis treated with orally administered difluoromethylornithine. The first case tolerated well his treatment (35 days of DFMO) and has probably been definitively cured. The second case, already in a desperate condition upon admission, died after only 4 days of difluoromethylornithine (DFMO). The authors hypothesize that difluoromethylornithine (DFMO) may be the drug of choice for congenital trypanosomiasis because of its good absorption by the oral route, its ability to penetrate the cerebrospinal fluid especially in presence of meningeal inflammation and its activity against Trypanosoma brucei-gambiense.
- Published
- 1989
30. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness
- Author
-
C. Guern, F. Milord, Jacques Pépin, and P. J. Schechter
- Subjects
Diarrhea ,Male ,Eflornithine ,Adolescent ,medicine.medical_treatment ,Trypanosoma brucei gambiense ,Drug Resistance ,Administration, Oral ,Melarsoprol ,Drug resistance ,Pharmacology ,Biology ,Arsenicals ,Ornithine decarboxylase ,Cerebrospinal fluid ,Recurrence ,medicine ,Animals ,Humans ,Child ,Infusions, Intravenous ,Chemotherapy ,General Medicine ,medicine.disease ,Hair loss ,Trypanosomiasis, African ,Child, Preschool ,Immunology ,Female ,Trypanosomiasis ,medicine.drug ,Follow-Up Studies - Abstract
26 patients with arseno-resistant Trypanosoma brucei gambiense trypanosomiasis were treated with difluoromethylornithine (eflornithine), an inhibitor of ornithine decarboxylase, given intravenously, then orally. There was rapid disappearance of trypanosomes in the cerebrospinal fluid (CSF), gradual decrease of CSF lymphocytosis, and parallel improvement in central nervous system status. Side-effects, including diarrhoea, anaemia, and hair loss, were common but tolerable and reversible. 5 patients died during or shortly after treatment. None of the 21 patients who completed therapy has had a relapse during the 6-30 month follow-up.
- Published
- 1987
31. [Integration of African human trypanosomiasis control in a network of multipurpose health centers]
- Author
-
J, Pepin, C, Guern, F, Milord, and M, Bokelo
- Subjects
Trypanosomiasis, African ,Trypanosoma brucei gambiense ,Carrier State ,Democratic Republic of the Congo ,Workforce ,Animals ,Mass Screening ,Community Health Centers ,Mobile Health Units ,Research Article - Abstract
The authors relate their experience of integrating screening for African human trypanosomiasis (AHT) caused by T.b. gambiense in a network of multi-purpose health centres at Nioki, Zaire. Since 1983 the health centre nurses have been trained in the laboratory techniques for AHT screening and have been given the essential equipment (microscope, slides, coverslips). The strategy used was that of passive screening of patients who came of their own accord to the health centre: systematic palpation and aspiration of lymph nodes, and examination of wet and/or thick blood films from patients with AHT-like symptoms (fever not responding to antimalarials, headache for over a week, somnolence, arthralgias, pruritus, weight loss). When a trypanosome was detected, the patient was referred to the hospital for confirmation and lumbar puncture. From 1983 to 1987 the proportion of new cases detected by the health centres rose from 0% to 31.1%, while the returns of the mobile teams diminished as the disease regressed. Nevertheless, only 22.1% of the new cases detected by the health centres had normal CSF, as opposed to 64.8% of the new cases detected actively by the mobile teams. These two approaches therefore seem to be complementary: 83% of the new cases detected by the health centres were diagnosed on lymph node aspirates and/or wet films, and it is likely that better use of thick blood films could improve the performance of the health centres.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1989
32. Self-reported tick exposure as an indicator of Lyme disease risk in an endemic region of Quebec, Canada.
- Author
-
Bowser N, Bouchard C, Sautié Castellanos M, Baron G, Carabin H, Chuard P, Leighton P, Milord F, Richard L, Savage J, Tardy O, and Aenishaenslin C
- Subjects
- Animals, Humans, Quebec epidemiology, Self Report, Cross-Sectional Studies, Canada epidemiology, Lyme Disease epidemiology, Ixodes, Tick Bites
- Abstract
Background: Lyme disease (LD) and other tick-borne diseases are emerging across Canada. Spatial and temporal LD risk is typically estimated using acarological surveillance and reported human cases, the former not considering human behavior leading to tick exposure and the latter occurring after infection., Objectives: The primary objective was to explore, at the census subdivision level (CSD), the associations of self-reported tick exposure, alternative risk indicators (predicted tick density, eTick submissions, public health risk level), and ecological variables (Ixodes scapularis habitat suitability index and cumulative degree days > 0 °C) with incidence proportion of LD. A secondary objective was to explore which of these predictor variables were associated with self-reported tick exposure at the CSD level., Methods: Self-reported tick exposure was measured in a cross-sectional populational health survey conducted in 2018, among 10,790 respondents living in 116 CSDs of the Estrie region, Quebec, Canada. The number of reported LD cases per CSD in 2018 was obtained from the public health department. Generalized linear mixed-effets models accounting for spatial autocorrelation were built to fulfill the objectives., Results: Self-reported tick exposure ranged from 0.0 % to 61.5 % (median 8.9 %) and reported LD incidence rates ranged from 0 to 324 cases per 100,000 person-years, per CSD. A positive association was found between self-reported tick exposure and LD incidence proportion (ß = 0.08, CI = 0.04,0.11, p < 0.0001). The best-fit model included public health risk level (AIC: 144.2), followed by predicted tick density, ecological variables, self-reported tick exposure and eTick submissions (AIC: 158.4, 158.4, 160.4 and 170.1 respectively). Predicted tick density was the only significant predictor of self-reported tick exposure (ß = 0.83, CI = 0.16,1.50, p = 0.02)., Discussion: This proof-of-concept study explores self-reported tick exposure as a potential indicator of LD risk using populational survey data. This approach may offer a low-cost and simple tool for evaluating LD risk and deserves further evaluation., Competing Interests: Declaration of Competing Interest The authors declare they have nothing to disclose., (Copyright © 2023. Published by Elsevier GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
33. Current and future burden from Lyme disease in Québec as a result of climate change.
- Author
-
Ripoche M, Irace-Cima A, Adam-Poupart A, Baron G, Bouchard C, Carignan A, Milord F, Ouhoummane N, Pilon PA, Thivierge K, Zinszer K, and Chaumont D
- Abstract
Context: Environmental changes will foster the spread of Ixodes scapularis ticks and increase the incidence of Lyme disease in Québec in the coming years. The objective of this study is to estimate the epidemiological and clinical burden and part of the current economic burden of Lyme disease in Québec and to estimate the number of cases expected by 2050., Methods: Cases of Lyme disease reported in Québec from 2015 to 2019 were used to describe their demographic, geographical and clinical characteristics and the cost of their initial care. Three incidence rate scenarios were then developed to estimate the number of cases expected by 2050, based on demographic and climate projections., Results: From 2016 to 2019, 1,473 cases of Lyme disease were reported in Québec. Over 90% of those cases were acquired in two regions of southern Québec (Estrie and Montérégie), while the individuals infected were residents from all over Québec. The average age of cases is 44 years and 66% of infections were at the localized stage, the first stage of Lyme disease. The cost of initial care is estimated at an average of $182 CAN per patient ($47 CAN at the localized stage and $443 CAN at the disseminated stage). According to projections, over 95% of the Québec population will live in a climate zone conducive to the establishment of ticks by 2050, with a number of cases acquired in Québec being 1.3 to 14.5 times higher than in 2019, depending on the incidence rate scenario used., Conclusion: The epidemiological burden is concentrated primarily in southern Québec, but the clinical and economic burden is already distributed throughout the province. The projections for 2050 should help the regions of Québec adapt and optimize public health protection measures., Competing Interests: Competing interests None.
- Published
- 2023
- Full Text
- View/download PDF
34. Integrated human behavior and tick risk maps to prioritize Lyme disease interventions using a 'One Health' approach.
- Author
-
Bouchard C, Dumas A, Baron G, Bowser N, Leighton PA, Lindsay LR, Milord F, Ogden NH, and Aenishaenslin C
- Subjects
- Animals, Humans, Cross-Sectional Studies, Bayes Theorem, Canada epidemiology, Lyme Disease epidemiology, Lyme Disease prevention & control, Ixodes, Tick Bites
- Abstract
Lyme disease (LD) risk is emerging rapidly in Canada due to range expansion of its tick vectors, accelerated by climate change. The risk of contracting LD varies geographically due to variability in ecological characteristics that determine the hazard (the densities of infected host-seeking ticks) and vulnerability of the human population determined by their knowledge and adoption of preventive behaviors. Risk maps are commonly used to support public health decision-making on Lyme disease, but the ability of the human public to adopt preventive behaviors is rarely taken into account in their development, which represents a critical gap. The objective of this work was to improve LD risk mapping using an integrated social-behavioral and ecological approach to: (i) compute enhanced integrated risk maps for prioritization of interventions and (ii) develop a spatially-explicit assessment tool to examine the relative contribution of different risk factors. The study was carried out in the Estrie region located in southern Québec. The blacklegged tick, Ixodes scapularis, infected with the agent of LD is widespread in Estrie and as a result, regional LD incidence is the highest in the province. LD knowledge and behaviors in the population were measured in a cross-sectional health survey conducted in 2018 reaching 10,790 respondents in Estrie. These data were used to create an index for the social-behavioral component of risk in 2018. Local Empirical Bayes estimator technique were used to better quantify the spatial variance in the levels of adoption of LD preventive activities. For the ecological risk analysis, a tick abundance model was developed by integrating data from ongoing long-term tick surveillance programs from 2007 up to 2018. Social-behavioral and ecological components of the risk measures were combined to create vulnerability index maps and, with the addition of human population densities, prioritization index maps. Map predictions were validated by testing the association of high-risk areas with the current spatial distribution of human cases of LD and reported tick exposure. Our results demonstrated that social-behavioral and ecological components of LD risk have markedly different distributions within Estrie. The occurrence of human LD cases or reported tick exposure in a municipality was positively associated with tick density and the prioritization risk index (p < 0.001). This research is a second step towards a more comprehensive integrated LD risk assessment approach, examining social-behavioral risk factors that interact with ecological risk factors to influence the management of emerging tick-borne diseases, an approach that could be applied more widely to vector-borne and zoonotic diseases., Competing Interests: Declaration of Competing Interest None., (Crown Copyright © 2022. Published by Elsevier GmbH. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
35. Quality over quantity in active tick surveillance: Sentinel surveillance outperforms risk-based surveillance for tracking tick-borne disease emergence in southern Canada.
- Author
-
Guillot C, Bouchard C, Buhler K, Pelletier R, Milord F, and Leighton P
- Abstract
Background: Lyme disease (LD) emerged in southern Québec at the start of the century, with many municipalities now endemic. A coordinated active surveillance programme has been in place in the province of Québec since 2014, including a limited number of sentinel field sites resampled each year and a larger set of accessory field sites that change yearly according to the LD surveillance signal. We aimed to evaluate whether a sentinel approach to active surveillance was more representative of LD risk to human populations, compared to risk-based surveillance., Methods: We compared enzootic hazard measures (average nymph densities) from sentinel and accessory sites with LD risk (number of human LD cases) across the study area between 2015 and 2019 using local bivariate Moran's I analysis., Results: Hazard measures from sentinel sites captured spatial risk significantly better than data from accessory sites (χ
2 =20.473, p <0.001). In addition, sentinel sites successfully tracked the interannual trend in LD case numbers, whereas accessory sites showed no association despite the larger sample size., Conclusion: Where surveillance aims to document changes in tick-borne disease risk over time and space, we suggest that repeated sampling of carefully selected field sites may be most effective, while risk-based surveillance may be more usefully applied to confirm the presence of emerging disease risk in a specific region of interest or to identify suitable sites for long-term monitoring as LD and other tick-borne diseases continue to emerge., Competing Interests: Competing interests None.- Published
- 2023
36. Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: A decision tool.
- Author
-
Guillot C, Bouchard C, Aenishaenslin C, Berthiaume P, Milord F, and Leighton PA
- Subjects
- Humans, Cost-Benefit Analysis, Canada, Public Health, Vector Borne Diseases
- Abstract
Objectives: With vector-borne diseases emerging across the globe, precipitated by climate change and other anthropogenic changes, it is critical for public health authorities to have well-designed surveillance strategies in place. Sentinel surveillance has been proposed as a cost-effective approach to surveillance in this context. However, spatial design of sentinel surveillance system has important impacts on surveillance outcomes, and careful selection of sentinel unit locations is therefore an essential component of planning., Methods: A review of the available literature, based on the realist approach, was used to identify key decision issues for sentinel surveillance planning. Outcomes of the review were used to develop a decision tool, which was subsequently validated by experts in the field., Results: The resulting decision tool provides a list of criteria which can be used to select sentinel unit locations. We illustrate its application using the case example of designing a national sentinel surveillance system for Lyme disease in Canada., Conclusions: The decision tool provides researchers and public health authorities with a systematic, evidence-based approach for planning the spatial design of sentinel surveillance systems, taking into account the aims of the surveillance system and disease and/or context-specific considerations., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Guillot, Bouchard, Aenishaenslin, Berthiaume, Milord and Leighton.)
- Published
- 2022
- Full Text
- View/download PDF
37. An ecological approach to predict areas with established populations of Ixodes scapularis in Quebec, Canada.
- Author
-
Hammond-Collins K, Tremblay M, Milord F, Baron G, Bouchard C, Kotchi SO, Lambert L, Leighton P, Ogden NH, and Rees EE
- Abstract
Public health management of Lyme disease (LD) is a dynamic challenge in Canada. Climate warming is driving the northward expansion of suitable habitat for the tick vector, Ixodes scapularis. Information about tick population establishment is used to inform the risk of LD but is challenged by sampling biases from surveillance data. Misclassifying areas as having no established tick population underestimates the LD risk classification. We used a logistic regression model at the municipal level to predict the probability of I. scapularis population establishment based on passive tick surveillance data during the period of 2010-2017 in southern Quebec. We tested for the effect of abiotic and biotic factors hypothesized to influence tick biology and ecology. Additional variables controlled for sampling biases in the passive surveillance data. In our final selected model, tick population establishment was positively associated with annual cumulative degree-days > 0°C, precipitation and deer density, and negatively associated with coniferous and mixed forest types. Sampling biases from passive tick surveillance were controlled for using municipal population size and public health instructions on tick submissions. The model performed well as indicated by an area under the curve (AUC) of 0.92, sensitivity of 86% and specificity of 81%. Our model enables prediction of I. scapularis population establishment in areas which lack data from passive tick surveillance and may improve the sensitivity of LD risk categorization in these areas. A more sensitive system of LD risk classification is important for increasing awareness and use of protective measures employed against ticks, and decreasing the morbidity associated with LD., Competing Interests: Declaration of Competing Interest None., (Crown Copyright © 2022. Published by Elsevier GmbH. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Environmental Investigation during Legionellosis Outbreak, Montérégie, Quebec, Canada, 2021.
- Author
-
Atikessé L, Kadaoui N, Lavallée V, Levac É, St-Amour M, and Milord F
- Subjects
- Humans, Quebec epidemiology, Disease Outbreaks, Canada, Water Microbiology, Legionellosis epidemiology, Legionella pneumophila genetics, Legionnaires' Disease epidemiology
- Abstract
In August 2021, a legionellosis outbreak involving 7 persons occurred within a 500-meter radius in the Montérégie region of Québec, Canada. Near real-time modeling of wind direction along with epidemiologic and environmental investigations identified the possible source. Modeling wind direction could help identify likely Legionella pneumophila sources during legionellosis outbreaks.
- Published
- 2022
- Full Text
- View/download PDF
39. Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.
- Author
-
Musonera JB, Valiquette L, Baron G, Milord F, Marcoux D, Thivierge K, Bedard-Dallaire S, Pelletier AA, Lachance R, Bourget J, Simard C, Cantin E, Abbasi F, Haraoui LP, and Carignan A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Canada, Child, Child, Preschool, Cohort Studies, Humans, Middle Aged, Prospective Studies, Quebec epidemiology, Retrospective Studies, Young Adult, Lyme Disease diagnosis, Lyme Disease drug therapy, Lyme Disease epidemiology, Post-Lyme Disease Syndrome
- Abstract
Background: Despite increases in cases of Lyme disease, little is known about the management and clinical course of the disease in Canada. We aimed to describe the management and clinical course of Lyme disease in patients treated in acute care facilities in Quebec and to assess adherence to the 2006 Infectious Diseases Society of America (IDSA) guideline., Methods: This retrospective multicentre cohort study included pediatric and adult patients with serologically confirmed Lyme disease treated in acute care facilities (12 community hospitals and 2 tertiary care centres) of 2 endemic regions of Quebec (Estrie and Montérégie), from 2004 to 2017. We considered drug choice, prescribed dose and treatment duration in assessing adherence of prescriptions to the 2006 IDSA guideline. The main outcome was complete resolution of symptoms at 3 months after the initiation of treatment., Results: We included 272 patients from 14 institutions (age range 3-87 yr). Early disseminated Lyme disease (140 patients [51%]) was predominant. Adherence to the IDSA guideline was observed in 235 (90%) of the 261 cases with complete information, and adherence was stable over time (2004-2013: 57/64 [89%]; 2014-2015: 64/71 [90%]; 2016-2017: 114/126 [90%]; p = 0.8). Non-adherence to the guideline ( n = 26) was predominantly due to longer-than-recommended treatment duration (16/26 [62%]). Resolution of objective signs at 3 months after treatment initiation occurred in 265 (99%) of 267 patients, whereas post-treatment Lyme disease syndrome was observed in 27 patients (10%) with increasing incidence over time (2004-2013: 3/65 [5%]; 2014-2015: 4/73 [5%]; 2016-2017: 20/129 [16%]; p = 0.02)., Interpretation: We observed clinical resolution of Lyme disease in 99% of the patients, and most treatments (90%) complied with the 2006 IDSA guideline. The incidence of post-treatment Lyme disease syndrome increased over the study period, warranting further prospective studies., Competing Interests: Competing interests: For work unrelated to the current study, Emmanuelle Cantin has received grants from the Centre de recherche du CHU Sherbrooke. No other competing interests were declared., (© 2022 CMA Impact Inc. or its licensors.)
- Published
- 2022
- Full Text
- View/download PDF
40. Sentinel Surveillance Contributes to Tracking Lyme Disease Spatiotemporal Risk Trends in Southern Quebec, Canada.
- Author
-
Guillot C, Bouchard C, Buhler K, Dumas A, Milord F, Ripoche M, Pelletier R, and Leighton PA
- Abstract
Lyme disease (LD) is a tick-borne disease which has been emerging in temperate areas in North America, Europe, and Asia. In Quebec, Canada, the number of human LD cases is increasing rapidly and thus surveillance of LD risk is a public health priority. In this study, we aimed to evaluate the ability of active sentinel surveillance to track spatiotemporal trends in LD risk. Using drag flannel data from 2015-2019, we calculated density of nymphal ticks (DON), an index of enzootic hazard, across the study region (southern Quebec). A Poisson regression model was used to explore the association between the enzootic hazard and LD risk (annual number of human cases) at the municipal level. Predictions from models were able to track both spatial and interannual variation in risk. Furthermore, a risk map produced by using model predictions closely matched the official risk map published by provincial public health authorities, which requires the use of complex criteria-based risk assessment. Our study shows that active sentinel surveillance in Quebec provides a sustainable system to follow spatiotemporal trends in LD risk. Such a network can support public health authorities in informing the public about LD risk within their region or municipality and this method could be extended to support Lyme disease risk assessment at the national level in Canada.
- Published
- 2022
- Full Text
- View/download PDF
41. Behavioral risk factors associated with reported tick exposure in a Lyme disease high incidence region in Canada.
- Author
-
Aenishaenslin C, Charland K, Bowser N, Perez-Trejo E, Baron G, Milord F, and Bouchard C
- Subjects
- Adult, Animals, Canada epidemiology, Cross-Sectional Studies, Health Knowledge, Attitudes, Practice, Humans, Incidence, Risk Factors, Surveys and Questionnaires, Lyme Disease epidemiology, Lyme Disease prevention & control, Tick Bites epidemiology, Tick Bites prevention & control, Tick-Borne Diseases epidemiology, Ticks
- Abstract
Background: Tick-borne diseases, and especially Lyme Disease (LD), are on the rise in Canada and have been met with increasing public health concern. To face these emerging threats, education on the prevention of tick bites remains the mainstay of public health intervention. The objective of this study was to assess the adoption of preventive behaviors toward tick bites and LD and to investigate the association between behavioral risk factors and reported tick exposure in a Canadian, LD high incidence region (Estrie region, Quebec, Canada)., Methods: A cross-sectional study was conducted in 2018 which used a telephone questionnaire administered to a random sample of 10,790 adult residents of the study region. Questions investigated tick exposure, LD awareness, attitudes towards LD risk, outdoor and preventive behaviors, as well as antibiotic post-exposure prophylaxis (PEP) treatments in the case of a tick bite. Descriptive and multivariable analyses were carried out, considering the nine administrative subregions and the stratified survey design., Results: The sub-regional prevalence of reported tick exposure in the previous year ranged from 3.4 to 21.9%. The proportion of respondents that adopted preventive behaviors varied from 27.0% (tick checks) to 30.1% (tick repellent) and 44.6% (shower after outdoor activities). A minority of respondents (15.9%) that sought healthcare after a tick bite received a PEP treatment. Performing tick checks (Odds ratio = 4.33), time spent outdoors (OR = 3.09) and living in a subregion with a higher public health LD risk level (OR = 2.14) were associated with reported tick exposure in multivariable models., Conclusions: This study highlights the low level of adoption of preventive behaviors against tick bites in a region where LD risk is amongst the highest in Canada. This suggests a concerning lack of improvement in LD prevention, as low levels of adoption were already reported in studies conducted in the last decade. Innovative and evidence-based approaches to improve education on ticks and tick-borne diseases and to promote behavior changes are urgently needed in Canada., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
42. Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012-2013.
- Author
-
Ouhoummane N, Tchouaket E, Lowe AM, Fortin A, Kairy D, Vibien A, Kovitz-Lensch J, Tannenbaum TN, and Milord F
- Subjects
- Aged, Female, Health Care Costs statistics & numerical data, Hospitalization economics, Hospitalization statistics & numerical data, Humans, Male, Middle Aged, Quebec epidemiology, Retrospective Studies, Surveys and Questionnaires, West Nile Fever epidemiology, Cost of Illness, Costs and Cost Analysis statistics & numerical data, West Nile Fever economics
- Abstract
The economic burden of West Nile virus (WNV) infection is not known for Canada. We sought to describe the direct and indirect costs of WNV infection in the province of Quebec, Canada, up to 2 years after onset of signs and symptoms. We conducted a retrospective cohort study that included WNV cases reported during 2012 and 2013. For 90 persons infected with WNV, persons with encephalitis accounted for the largest proportion of total cost: a median cost of $21,332 per patient compared with $8,124 for West Nile meningitis (p = 0.0004) and $192 for West Nile fever (p<0.0001). When results were extrapolated to all reported WNV patients, the estimated total cost for 124 symptomatic cases was ≈$1.7 million for 2012 and that for 31 symptomatic cases was ≈$430,000 for 2013. Our study provides information for the government to make informed decisions regarding public health policies and infectious diseases prevention and control programs.
- Published
- 2019
- Full Text
- View/download PDF
43. Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Québec, Canada.
- Author
-
Gasmi S, Bouchard C, Ogden NH, Adam-Poupart A, Pelcat Y, Rees EE, Milord F, Leighton PA, Lindsay RL, Koffi JK, and Thivierge K
- Subjects
- Animals, Female, Humans, Lyme Disease epidemiology, Lyme Disease transmission, Quebec epidemiology, Ixodes classification, Population Density, Public Health Surveillance, Tick Infestations epidemiology
- Abstract
Climate change is driving emergence and establishment of Ixodes scapularis, the main vector of Lyme disease in Québec, Canada. As for the black-legged tick, I. scapularis Say, global warming may also favor northward expansion of other species of medically important ticks. The aims of this study were to determine (1) current diversity and abundance of ticks of public health significance other than I. scapularis, (2) sex and age of the human population bitten by these ticks (3), and the seasonal and geographic pattern of their occurrence. From 2007 to 2015, twelve tick species other than I. scapularis were submitted in the Québec passive tick surveillance program. Of these 9243 ticks, 91.2% were Ixodes cookei, 4.1% were Dermacentor variabilis, 4.0% were Rhipicephalus sanguineus and 0.7% were Amblyomma americanum. The combined annual proportion of submitted I. cookei, D. variabilis, R. sanguineus and A. americanum ticks in passive surveillance rose from 6.1% in 2007 to 16.0% in 2015 and an annual growing trend was observed for each tick species. The number of municipalities where I. cookei ticks were acquired rose from 104 to 197 during the same period. Of the 862 people bitten by these ticks, 43.3% were I. cookei ticks removed from children aged < 10 years. These findings demonstrate the need for surveillance of all the tick species of medical importance in Québec, particularly because climate may increase their abundance and geographic ranges, increasing the risk to the public of the diseases they transmit., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
44. Passive Tick Surveillance Provides an Accurate Early Signal of Emerging Lyme Disease Risk and Human Cases in Southern Canada.
- Author
-
Ripoche M, Gasmi S, Adam-Poupart A, Koffi JK, Lindsay LR, Ludwig A, Milord F, Ogden NH, Thivierge K, and Leighton PA
- Subjects
- Animals, Epidemiological Monitoring, Humans, Ixodes growth & development, Lyme Disease microbiology, Nymph growth & development, Nymph physiology, Population Density, Quebec epidemiology, Regression Analysis, Risk Factors, Tick Infestations parasitology, Ixodes physiology, Lyme Disease epidemiology, Population Surveillance methods, Tick Infestations epidemiology
- Abstract
Lyme disease is an emerging public health threat in Canada. In this context, rapid detection of new risk areas is essential for timely application of prevention and control measures. In Canada, information on Lyme disease risk is collected through three surveillance activities: active tick surveillance, passive tick surveillance, and reported human cases. However, each method has shortcomings that limit its ability to rapidly and reliably identify new risk areas. We investigated the relationships between risk signals provided by human cases, passive and active tick surveillance to assess the performance of tick surveillance for early detection of emerging risk areas. We used regression models to investigate the relationships between the reported human cases, Ixodes scapularis (Say; Acari: Ixodidae) ticks collected on humans through passive surveillance and the density of nymphs collected by active surveillance from 2009 to 2014 in the province of Quebec. We then developed new risk indicators and validated their ability to discriminate risk levels used by provincial public health authorities. While there was a significant positive relationship between the risk signals provided all three surveillance methods, the strongest association was between passive tick surveillance and reported human cases. Passive tick submissions were a reasonable indicator of the abundance of ticks in the environment (sensitivity and specificity [Se and Sp] < 0.70), but were a much better indicator of municipalities with more than three human cases reported over 5 yr (Se = 0.88; Sp = 0.90). These results suggest that passive tick surveillance provides a timely and reliable signal of emerging risk areas for Lyme disease in Canada.
- Published
- 2018
- Full Text
- View/download PDF
45. The changing landscape of travel health services in Canada.
- Author
-
Bui YG, Kuhn SM, Sow M, McCarthy AE, Geduld J, and Milord F
- Subjects
- Canada, Humans, Travel Medicine economics, Travel-Related Illness, Vaccination statistics & numerical data, Yellow Fever prevention & control, Travel Medicine organization & administration
- Abstract
Canadians are increasingly travelling to areas that would necessitate a pre-travel consultation. Changes in professional regulations in Canada allow greater autonomy of nurses and pharmacists, resulting in shifts in provision of travel health services. We surveyed 824 Canadian travel clinics, 270 (33%) of whom responded. Private clinics were most common, and more likely to offer extended hours and drop-in appointments. In one province, pharmacies dominated. Half the services were relatively new and a similar proportion saw fewer than 10 patients weekly; 1/3 had a single provider. The increased spectrum of services may increase convenience for travellers but the large proportion seeing low numbers of clients will challenge providers to maintain competence.
- Published
- 2018
- Full Text
- View/download PDF
46. Morbidity, mortality and long-term sequelae of West Nile virus disease in Québec.
- Author
-
Ouhoumanne N, Lowe AM, Fortin A, Kairy D, Vibien A, K-Lensch J, Tannenbaum TN, and Milord F
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Morbidity, Prospective Studies, Quebec epidemiology, Severity of Illness Index, West Nile Fever virology, Young Adult, West Nile Fever complications, West Nile Fever epidemiology, West Nile virus physiology
- Abstract
We aimed to describe the clinical characteristics of West Nile patients reported in Québec in 2012 and 2013 and to document physical, mental and functional status 24 months after symptom onset according to illness severity. The cases were recruited by a public health professional. Data were collected from public health files, medical records and two standardised phone questionnaires: the Short Form-36 and the Instrumental Activities of Daily Living. In all, 92 persons participated in the study (25 had West Nile fever (WNF), 18 had meningitis and 49 had encephalitis). Encephalitis participants were older, had more underlying medical conditions, more neurological symptoms, worse hospital course and higher lethality than meningitis or WNF participants. Nearly half of the surviving hospitalised encephalitis patients required extra support upon discharge. At 24-month follow-up, encephalitis and meningitis patients had a lower score in two domains of the mental component: mental health and social functioning (P = 0.0025 and 0.0297, respectively) compared with the norms based on age- and sex-matched Canadians. Physical status was not affected by West Nile virus (WNV) infection. In addition, 5/36 (15%) of encephalitis, 1/17 (6%) of meningitis and 1/23 (5%) of WNF participants had new functional limitations 24 months after symptom onset. In summary, mental and functional sequelae in encephalitis patients are likely to represent a source of long-term morbidity. Preventive measures should target patients at higher risk of severe illness after WNV infection.
- Published
- 2018
- Full Text
- View/download PDF
47. Integrated Social-Behavioral and Ecological Risk Maps to Prioritize Local Public Health Responses to Lyme Disease.
- Author
-
Bouchard C, Aenishaenslin C, Rees EE, Koffi JK, Pelcat Y, Ripoche M, Milord F, Lindsay LR, Ogden NH, and Leighton PA
- Subjects
- Humans, Lyme Disease microbiology, Prevalence, Quebec epidemiology, Socioeconomic Factors, Geographic Mapping, Lyme Disease epidemiology, Risk Assessment methods
- Abstract
Background: The risk of contracting Lyme disease (LD) can vary spatially because of spatial heterogeneity in risk factors such as social-behavior and exposure to ecological risk factors. Integrating these risk factors to inform decision-making should therefore increase the effectiveness of mitigation interventions., Objectives: The objective of this study was to develop an integrated social-behavioral and ecological risk-mapping approach to identify priority areas for LD interventions., Methods: The study was conducted in the Montérégie region of Southern Quebec, Canada, where LD is a newly endemic disease. Spatial variation in LD knowledge, risk perceptions, and behaviors in the population were measured using web survey data collected in 2012. These data were used as a proxy for the social-behavioral component of risk. Tick vector population densities were measured in the environment during field surveillance from 2007 to 2012 to provide an index of the ecological component of risk. Social-behavioral and ecological components of risk were combined with human population density to create integrated risk maps. Map predictions were validated by testing the association between high-risk areas and the current spatial distribution of human LD cases., Results: Social-behavioral and ecological components of LD risk had markedly different distributions within the study region, suggesting that both factors should be considered for locally adapted interventions. The occurrence of human LD cases in a municipality was positively associated with tick density ( p <0.01) but was not significantly associated with social-behavioral risk., Conclusion: This study is an applied demonstration of how integrated social-behavioral and ecological risk maps can be created to assist decision-making. Social survey data are a valuable but underutilized source of information for understanding regional variation in LD exposure, and integrating this information into risk maps provides a novel approach for prioritizing and adapting interventions to the local characteristics of target populations. https://doi.org/10.1289/EHP1943.
- Published
- 2018
- Full Text
- View/download PDF
48. Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015.
- Author
-
Gasmi S, Ogden NH, Leighton PA, Adam-Poupart A, Milord F, Lindsay LR, Barkati S, and Thivierge K
- Subjects
- Animals, Anti-Infective Agents therapeutic use, Humans, Ixodes, Lyme Disease drug therapy, Lyme Disease therapy, Quebec, Retrospective Studies, Surveys and Questionnaires, Tick Bites complications, Tick Bites drug therapy, Tick Bites therapy, General Practitioners statistics & numerical data, Lyme Disease diagnosis, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Background: Lyme disease (LD), a multisystem infection caused by the spirochete Borrelia burgdorferi sensu stricto (B. burgdorferi), is the most reported vector-borne disease in North America, and by 2020, 80% of the population in central and eastern Canada could live in LD risk areas. Among the key factors for minimising the impact of LD are the accurate diagnosis and appropriate management of patients bitten by ticks. In this study, the practices of Quebec general practitioners (GPs) on LD diagnosis and management of patients bitten by infected ticks are described., Methods: Eight years (2008 to 2015) of retrospective demographic and clinical data on patients bitten by infected Ixodes scapularis (I. scapularis) ticks and on the management of suspected and confirmed LD cases by Quebec GPs were analysed., Results: Among 50 patients, all the antimicrobial treatments of LD clinical cases were appropriate according to current guidelines. However, more than half (62.8%) of erythema migrans (EM) were possibly misdiagnosed, 55.6%, (n = 27) of requested serologic tests were possibly unnecessary and the majority (96.5%, n = 57) of prophylactic antimicrobial treatments were not justified according to current guidelines., Conclusions: These observations underline the importance for public health to enhance the knowledge of GPs where LD is emerging, to minimise the impact of the disease on patients and the financial burden on the health system.
- Published
- 2017
- Full Text
- View/download PDF
49. Acceptability of tick control interventions to prevent Lyme disease in Switzerland and Canada: a mixed-method study.
- Author
-
Aenishaenslin C, Michel P, Ravel A, Gern L, Waaub JP, Milord F, and Bélanger D
- Subjects
- Adolescent, Adult, Aged, Animals, Canada, Endemic Diseases, Humans, Insecticides, Middle Aged, Public Health, Residence Characteristics, Risk, Surveys and Questionnaires, Switzerland, Young Adult, Attitude to Health, Lyme Disease prevention & control, Tick Control methods, Ticks
- Abstract
Background: Lyme disease control strategies may include tick control interventions in high risk areas. Public authorities may be interested to assess how these types of interventions are perceived by the public which may then impact their acceptability. The aims of this paper are to compare socio-cognitive factors associated with high acceptability of tick control interventions and to describe perceived issues that may explain their low acceptability in populations living in two different regions, one being an endemic region for LD since the last 30 years, the Neuchâtel canton, in Switzerland, and another where the disease is emerging, the Montérégie region, in Canada., Methods: A mixed methods' design was chosen. Quantitative data were collected using web-surveys conducted in both regions (n = 814). Multivariable logistic regressions were used to compare socio-cognitive factors associated with high acceptability of selected interventions. Qualitative data were collected using focus group's discussions to describe perceived issues relative to these interventions., Results: Levels of acceptability in the studied populations were the lowest for the use of acaricides and landscaping and were under 50 % in both regions for six out of eight interventions, but were higher overall in Montérégie. High perceived efficacy of the intervention was strongly associated with high acceptability of tick control interventions. A high perceived risk about LD was also associated with a high acceptability of intervention under some models. High level of knowledge about LD was negatively associated with high acceptability of the use of acaricides in Neuchâtel. Perceived issues explaining low acceptability included environmental impacts, high costs to the public system, danger of individual disempowerment and perceptions that tick control interventions were disproportionate options for the level of LD risk., Conclusion: This study suggests that the perceived efficacy and LD risk perception may be key factors to target to increase the acceptability of tick control interventions. Community-level issues seem to be important considerations driving low acceptability of public health interventions. Results of this study highlight the importance for decision-makers to account for socio-cognitive factors and perceived issues that may affect the acceptability of public health interventions in order to maximize the efficacy of actions to prevent and control LD.
- Published
- 2016
- Full Text
- View/download PDF
50. Adaptation and Evaluation of a Multi-Criteria Decision Analysis Model for Lyme Disease Prevention.
- Author
-
Aenishaenslin C, Gern L, Michel P, Ravel A, Hongoh V, Waaub JP, Milord F, and Bélanger D
- Subjects
- Acaricides, Animals, Borrelia burgdorferi pathogenicity, Borrelia burgdorferi physiology, Epidemiological Monitoring, Humans, Lyme Disease epidemiology, Lyme Disease microbiology, Public Health, Quebec epidemiology, Switzerland epidemiology, Tick Control economics, Decision Support Techniques, Ixodes microbiology, Lyme Disease prevention & control, Models, Statistical, Tick Control methods, Zoonoses prevention & control
- Abstract
Designing preventive programs relevant to vector-borne diseases such as Lyme disease (LD) can be complex given the need to include multiple issues and perspectives into prioritizing public health actions. A multi-criteria decision aid (MCDA) model was previously used to rank interventions for LD prevention in Quebec, Canada, where the disease is emerging. The aim of the current study was to adapt and evaluate the decision model constructed in Quebec under a different epidemiological context, in Switzerland, where LD has been endemic for the last thirty years. The model adaptation was undertaken with a group of Swiss stakeholders using a participatory approach. The PROMETHEE method was used for multi-criteria analysis. Key elements and results of the MCDA model are described and contrasted with the Quebec model. All criteria and most interventions of the MCDA model developed for LD prevention in Quebec were directly transferable to the Swiss context. Four new decision criteria were added, and the list of proposed interventions was modified. Based on the overall group ranking, interventions targeting human populations were prioritized in the Swiss model, with the top ranked action being the implementation of a large communication campaign. The addition of criteria did not significantly alter the intervention rankings, but increased the capacity of the model to discriminate between highest and lowest ranked interventions. The current study suggests that beyond the specificity of the MCDA models developed for Quebec and Switzerland, their general structure captures the fundamental and common issues that characterize the complexity of vector-borne disease prevention. These results should encourage public health organizations to adapt, use and share MCDA models as an effective and functional approach to enable the integration of multiple perspectives and considerations in the prevention and control of complex public health issues such as Lyme disease or other vector-borne and zoonotic diseases.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.